CHRS
Coherus BioSciences Inc
NASDAQ: CHRS · HEALTHCARE · BIOTECHNOLOGY
$1.74
-1.69% today
Updated 2026-04-29
Market cap
$262.31M
P/E ratio
—
P/S ratio
6.22x
EPS (TTM)
$-1.56
Dividend yield
—
52W range
$1 – $3
Volume
1.3M
Coherus BioSciences Inc (CHRS) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
2 of 8
Last 8 quarters
Avg EPS surprise
-58.3%
Last 4 quarters
Revenue YoY growth
-76.5%
Most recent quarter
EPS YoY growth
-21.4%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
-9.6%
Last 2 reports
Positive reaction rate
0%
0 of 2 quarters
Largest single-day move
-14.4%
2025-11-06
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-03-17 | $-0.34 | -0.5% | $1.66 | $1.58 | -4.8% |
| 2025-11-06 | $-0.33 | -3.1% | $1.57 | $1.34 | -14.4% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-12-31 | $-0.34 | $-0.34 | -0.5% | $12.75M | -76.5% |
| 2025-09-30 | $-0.32 | $-0.33 | -3.1% | $11.57M | -83.7% |
| 2025-06-30 | $-0.26 | $-0.39 | -50.0% | $10.25M | -84.2% |
| 2025-03-31 | $-0.13 | $-0.35 | -179.6% | $7.60M | +229.2% |
| 2024-12-31 | $-0.13 | $-0.28 | -114.6% | $54.14M | -40.8% |
| 2024-09-30 | $-0.12 | $-0.01 | +91.7% | $70.77M | -5.1% |
| 2024-06-30 | $-0.29 | $-0.14 | +51.7% | $64.98M | +10.7% |
| 2024-03-31 | $-0.24 | $-0.32 | -33.3% | $2.31M | -92.9% |
| 2023-12-31 | $-0.12 | $-0.62 | -416.7% | $91.52M | — |
| 2023-09-30 | $-0.27 | $-0.41 | -51.9% | $74.57M | — |
| 2023-06-30 | $-0.48 | $-0.38 | +20.8% | $58.72M | — |
| 2023-03-31 | $-0.57 | $-0.75 | -31.6% | $32.44M | — |
Frequently asked questions
Has Coherus BioSciences Inc beaten earnings estimates?
Coherus BioSciences Inc has beaten Wall Street EPS estimates in 2 of its last 8 quarterly reports, with an average EPS surprise of -58.3% over the last 4 quarters.
How does CHRS stock react to earnings?
CHRS stock has moved an average of -9.6% in the trading day following earnings over its last 2 reports, with positive reactions in 0% of those quarters.
What is Coherus BioSciences Inc's revenue growth rate?
Coherus BioSciences Inc reported year-over-year revenue growth of -76.5% in its most recent quarter, with EPS growing -21.4% year-over-year.